Fumihiko Ishikawa

Author PubWeight™ 48.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Humanized mice in translational biomedical research. Nat Rev Immunol 2007 8.83
2 Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat Biotechnol 2010 3.13
3 Cancer stem cell definitions and terminology: the devil is in the details. Nat Rev Cancer 2012 2.76
4 Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell 2011 2.62
5 Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice. Proc Natl Acad Sci U S A 2010 2.24
6 Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci Transl Med 2010 1.78
7 Characterization and distribution of bone marrow-derived cells in mouse cornea. Invest Ophthalmol Vis Sci 2005 1.33
8 Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival. J Immunol 2008 1.32
9 Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/SCID/IL2rγKO mice. J Immunol 2012 1.27
10 Il2rg gene-targeted severe combined immunodeficiency pigs. Cell Stem Cell 2012 1.24
11 Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation. Blood 2012 1.23
12 Hematopoietic origin of hepatic stellate cells in the adult liver. Blood 2007 1.11
13 Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness. J Exp Med 2005 1.07
14 Autoreactive T-cell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory. Gastroenterology 2006 1.07
15 A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivo. Sci Transl Med 2013 1.01
16 Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation. Transplantation 2006 0.92
17 Identification of hepatic niche harboring human acute lymphoblastic leukemic cells via the SDF-1/CXCR4 axis. PLoS One 2011 0.88
18 Mobilization of human lymphoid progenitors after treatment with granulocyte colony-stimulating factor. J Immunol 2005 0.87
19 Human cord blood--derived cells generate insulin-producing cells in vivo. Stem Cells 2005 0.86
20 Intracellular signal transduction of interferon on the suppression of haematopoietic progenitor cell growth. Br J Haematol 2003 0.86
21 Contribution of bone marrow-derived hematopoietic stem/progenitor cells to the generation of donor-marker⁺ cardiomyocytes in vivo. PLoS One 2013 0.83
22 Tyrosine kinase 2 interacts with and phosphorylates receptor for activated C kinase-1, a WD motif-containing protein. J Immunol 2004 0.83
23 In vivo repopulation of cytoplasmically gene transferred hematopoietic cells by temperature-sensitive mutant of recombinant Sendai viral vector. Biochem Biophys Res Commun 2007 0.82
24 Transplanted human cord blood cells generate amylase-producing pancreatic acinar cells in engrafted mice. Pancreas 2008 0.80
25 Identification of resident and inflammatory bone marrow derived cells in the sclera by bone marrow and haematopoietic stem cell transplantation. Br J Ophthalmol 2006 0.80
26 Peripheral tolerance and the qualitative characteristics of autoreactive T cell clones in primary biliary cirrhosis. J Immunol 2007 0.80
27 Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence. Leuk Res 2006 0.80
28 The lipocalin 24p3, which is an essential molecule in IL-3 withdrawal-induced apoptosis, is not involved in the G-CSF withdrawal-induced apoptosis. Eur J Haematol 2003 0.79
29 Clinical features and outcomes of 35 disseminated intravascular coagulation cases treated with recombinant human soluble thrombomodulin at a single institution. J Clin Exp Hematop 2011 0.77
30 Reconstitution of HLA-A*2402-restricted cytomegalovirus-specific T-cells following stem cell transplantation. Int J Hematol 2004 0.77
31 Limitin, an interferon-like cytokine, transduces inhibitory signals on B-cell growth through activation of Tyk2, but not Stat1, followed by induction and nuclear translocation of Daxx. Exp Hematol 2003 0.77
32 Characteristic morphology and distribution of bone marrow derived cells in the cornea. Anat Rec (Hoboken) 2009 0.76
33 The origins of blood: induction of hematopoietic stem cells from different sources. Cell Stem Cell 2008 0.76
34 Chronic graft-versus-host disease following varicella-zoster virus infection in allogeneic stem cell transplant recipients. Int J Hematol 2003 0.76
35 Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues. Cancer Sci 2011 0.76
36 Activation of T-cell receptor signaling in peripheral T-cell lymphoma cells plays an important role in the development of lymphoma-associated hemophagocytosis. Int J Hematol 2011 0.76
37 Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012). Intern Med 2015 0.75
38 [Four cases of operations for malignant disease in elderly patients]. Gan To Kagaku Ryoho 2014 0.75
39 [Three cases of endoscopic gastroduodenal stenting for gastric outlet obstruction caused by unresectable gastric cancer]. Gan To Kagaku Ryoho 2014 0.75
40 The Impact of a Humanized CCR4 Antibody (Mogamulizumab) on Patients with Aggressive-Type Adult T-Cell Leukemia-Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation. J Clin Exp Hematop 2017 0.75
41 [Development of therapeutic strategies targeting AML stem cells]. Nihon Rinsho 2014 0.75
42 [Conversion Therapy of Initially Unresectable Rectal Cancer with Perforation via FOLFOX4 Chemotherapy]. Gan To Kagaku Ryoho 2015 0.75
43 Clinical Features and Treatment Outcomes of 51 Patients with Chronic Myeloid Leukemia Treated with a Tyrosine Kinase Inhibitor at a Single Institution from 2002 to 2014. J Clin Exp Hematop 2016 0.75
44 [Establishment of human acute B-lymphoblastic leukemia NOD/SCID/IL2 receptor γ chain(null) neonatal mouse xenotransplant model]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012 0.75
45 Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014). Intern Med 2016 0.75
46 [Long-term control of stage IV breast and gastric cancer with combination therapy of S-1 and paclitaxel]. Gan To Kagaku Ryoho 2014 0.75
47 [Repeated Insertion of Self-Expandable Metallic Stents as a Palliative Therapy for Unresectable Colorectal Cancer]. Gan To Kagaku Ryoho 2015 0.75
48 [Reversible expression of CD34 by hematopoietic stem cells]. Rinsho Ketsueki 2002 0.75